Physician profile
Ronny Johnson
NPI 1922047018
$9,058.41
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,064 · 2020: $1,647 · 2021: $93.70 · 2022: $82.63 · 2023: $171.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $171.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $171.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $4,330.06 | 2019 | |
| Acell, INC. | $1,026.03 | 2019 | |
| Silk Road Medical, INC. | $1,007.71 | 2019-2020 | |
| Musculoskeletal Transplant Foundation INC. | $788.48 | 2020 | |
| Endologix LLC | $611.74 | 2019-2020 | |
| Medtronic Vascular, INC. | $399.07 | 2019-2020 | |
| Cook Medical LLC | $359.45 | 2019-2021 | |
| Medtronic, INC. | $227.15 | 2021-2023 | In.Pact Admiral |
| Lemaitre Vascular, INC. | $91.28 | 2019 | |
| Bard Peripheral Vascular, INC. | $61.65 | 2019-2020 | |
| Novo Nordisk INC | $34.54 | 2021 | |
| Organogenesis INC. | $29.15 | 2019 | |
| Abbott Laboratories | $24.12 | 2022 | |
| Antares Pharma, INC. | $17.37 | 2023 | Nocdurna, Tlando, Xyosted |
| W. L. Gore & Associates, INC. | $14.04 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Artivion, INC. | $13.04 | 2019 | |
| Ekos Corporation | $12.12 | 2019 | |
| Smith+Nephew, INC. | $11.41 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronny Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.